Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Pradaxa (dabigatran etexilate) – Oral Direct Thrombin Inhibitor

Drug (brand/generic)

Pradaxa (dabigatran etexilate)

Company/Licensee

Boehringer Ingelheim

Therapy Class

Anticoagulant

Product Description

Direct thrombin inhibitor

Current Indication

Primary prevention and treatment of VTE following orthopaedic surgery

Market Sector

Cardiovascular

Development Status

Approved in Europe, the US and Japan
Expand

Go Top